These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19051148)

  • 1. BioPartnering Europe--16th annual conference.
    Glah D; Bright J
    IDrugs; 2008 Dec; 11(12):880-3. PubMed ID: 19051148
    [No Abstract]   [Full Text] [Related]  

  • 2. Europe discovers bioentrepreneurship.
    Haycock P
    Nat Biotechnol; 1998 May; 16 Suppl():6. PubMed ID: 9591249
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotech meets the investors.
    Berry S
    Trends Biotechnol; 2002 Sep; 20(9):370-1. PubMed ID: 12175762
    [No Abstract]   [Full Text] [Related]  

  • 4. Divining the path to a successful European exit.
    Buch HK; Gustafsson AC; Drvota V; Sundberg CJ
    Nat Biotechnol; 2011 Mar; 29(3):205-7. PubMed ID: 21510008
    [No Abstract]   [Full Text] [Related]  

  • 5. Job insecurity.
    Smaglik P
    Nature; 2002 Oct; 419(6910):3. PubMed ID: 12410262
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioentrepreneurship around the world.
    Persidis A
    Nat Biotechnol; 1998 May; 16 Suppl():3-4. PubMed ID: 9591247
    [No Abstract]   [Full Text] [Related]  

  • 7. SOZO--a Euro-Japanese biotechnology conference.
    Veryard C
    IDrugs; 2005 Jul; 8(7):560-2. PubMed ID: 15973563
    [No Abstract]   [Full Text] [Related]  

  • 8. Western biotechs ponder follow-on possibilities.
    Waltz E
    Nat Biotechnol; 2008 Sep; 26(9):962-3. PubMed ID: 18779793
    [No Abstract]   [Full Text] [Related]  

  • 9. Shutters come off IPO window.
    Hodgson J
    Nat Biotechnol; 2002 Jan; 20(1):6. PubMed ID: 11753342
    [No Abstract]   [Full Text] [Related]  

  • 10. Europe's biotech renaissance.
    Senior M
    Nat Biotechnol; 2020 Apr; 38(4):408-415. PubMed ID: 32265563
    [No Abstract]   [Full Text] [Related]  

  • 11. The further evolution of biotech.
    Nagle T; Berg C; Nassr R; Pang K
    Nat Rev Drug Discov; 2003 Jan; 2(1):75-9. PubMed ID: 12509762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotechnology in Ireland: hard work, money and the brain gain.
    O'Neill MF
    Drug Discov Today; 2007 Feb; 12(3-4):108-11. PubMed ID: 17275730
    [No Abstract]   [Full Text] [Related]  

  • 13. The production capacity bottleneck.
    De Keyser JL
    Nat Biotechnol; 2001 Aug; 19(8):715. PubMed ID: 11479555
    [No Abstract]   [Full Text] [Related]  

  • 14. Biotech at the beauty counter.
    Nasto B
    Nat Biotechnol; 2007 Jun; 25(6):617-9. PubMed ID: 17557090
    [No Abstract]   [Full Text] [Related]  

  • 15. Sunbaked biotechnology in Australia.
    Littlejohn T
    Nat Biotechnol; 2002 Sep; 20(9):873-7. PubMed ID: 12205502
    [No Abstract]   [Full Text] [Related]  

  • 16. Built-to-buy start-ups begin to bloom.
    Mullard A
    Nat Rev Drug Discov; 2014 Mar; 13(3):161-2. PubMed ID: 24577386
    [No Abstract]   [Full Text] [Related]  

  • 17. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
    Scattereggia J
    IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotechs hold their own in shifting industry.
    Mitchell P
    Nat Biotechnol; 2002 Nov; 20(11):1065-6. PubMed ID: 12410238
    [No Abstract]   [Full Text] [Related]  

  • 19. Building for an exit (or not).
    Gunning TG
    Nat Biotechnol; 2008 Sep; 26(9):971-3. PubMed ID: 18792427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Change the world through business partnering - commercialization of biotechnology and open-innovation].
    Tsukamoto Y
    Nihon Yakurigaku Zasshi; 2013 May; 141(5):268-74. PubMed ID: 23665558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.